Abstract
Purpose
A heart rate >90 bpm serves as one of four characteristics defining the systemic inflammatory response syndrome and is used in scoring systems to predict in-hospital mortality of intensive care unit (ICU) patients. Despite its central role in critical illness, specific data regarding the relationship between heart rate and outcome are rare.
Methods
In this post hoc analysis of a prospectively collected database, we analyzed the value of heart rate averaged from four predefined time points during the last 24 h before ICU discharge as a predictor of post-ICU in-hospital and post-hospital mortality in medical ICU patients. Furthermore, the relationship between heart rate and inflammation, as well as the influence of rate control medications on the association between heart rate and outcome were identified.
Results
Among the 702 ICU patients discharged from the ICU, 7.1 % died before hospital discharge. At 4 years of follow-up, post-hospital mortality was 14.4 %. Multivariate Cox proportional hazards models revealed heart rate before ICU discharge (HR 5.95; 95 % CI 1.24–28.63; p = 0.03) as an independent predictor of post-ICU in-hospital mortality. Both heart rate (HR 2.56; 95 % CI, 1.05−6.34; p = 0.04) and the C-reactive protein serum concentration before ICU discharge (HR, 1.26; 95 % CI, 1.09–1.46; p = 0.002) were independently associated with post-hospital mortality. Heart rate control therapy reduced the risk of post-ICU in-hospital (HR 0.38; 95 % CI, 0.18–0.81; p = 0.01) and post-hospital (HR, 0.47; 95 % CI, 0.22–1.00; p = 0.05) mortality.
Conclusion
Heart rate evaluated 24 h before ICU discharge was independently associated with post-ICU in-hospital and post-hospital mortality. Pharmacological interventions to control heart rate may beneficially influence post-ICU mortality.
Similar content being viewed by others
References
Levine HJ (1997) Rest heart rate and life expectancy. J Am Coll Cardiol 30(4):1104–1106
Hoke RS, Muller-Werdan U, Lautenschlager C et al (2012) Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study. Clin Res Cardiol 101(2):139–147
Tracey KJ (2009) Reflex control of immunity. Nat Rev Immunol 9(6):418–428
Bone RC, Balk RA, Cerra FB et al (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 136(5 Suppl):e28
Kannel WB, Kannel C, Paffenbarger RS Jr et al (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113(6):1489–1494
Hansen TW, Thijs L, Boggia J et al (2008) Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations. Hypertension 52(2):229–235
Kristal-Boneh E, Silber H, Harari G, Froom P (2000) The association of resting heart rate with cardiovascular, cancer and all-cause mortality: eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 21:116–124
Lechat P, Hulot JS, Escolano S et al (2001) Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 103(10):1428–1433
Giannoglou GD, Chatzizisis YS, Zamboulis C et al (2008) Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 126(3):302–312
Palatini P, Julius S (2004) Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 26:637–644
Swedberg K, Komajda M, Bohm M et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875–885
Fox K, Ford I, Steg PG et al (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372(9641):807–816
Grander W, Dunser M, Stollenwerk B et al (2010) C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest 138(4):856–862
Grander W, Luckner G, Orgersen C et al (2011) Peak postoperative C-reactive protein levels and long-term mortality in a mixed surgical ICU population: a retrospective, observational-analytical study. Chirurgia 24(3):125–131
Ahmad S, Tejuja A, Newman KD et al (2009) Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection. Crit Care 13(6):232
Kox M, Vrouwenvelder MQ, Pompe JC et al (2011) The effects of brain injury on heart rate variability and the innate immune response in critically ill patients. J Neurotrauma 29(5):747–755
Pavlov VA, Tracey KJ (2006) Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans 34(Pt 6):1037–1040
Gallowitsch-Puerta M, Pavlov VA (2007) Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci 80(24–25):2325–2329
Ferrari R, Censi S, Mastrorilli F, Boraso A (2003) Prognostic effects of heart rate reduction in cardiovascular disease. Eur Heart J Suppl 5(Supplement):G10–G14
Giannoglou GD, Chatzizisis YS, Zamboulis C et al (2008) Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 126(3):302–312
Heidland UE, Strauer BE (2001) Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 104(13):1477–1482
Ho KM, Lee KY, Dobb GJ et al (2008) C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 34(3):481–487
Litton E, Ho KM, Chamberlain J et al (2007) C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a nested case-control study. Crit Care Resusc 9(1):19–25
Al-Subaie N, Reynolds T, Myers A et al (2010) C-reactive protein as a predictor of outcome after discharge from the intensive care: a prospective observational study. Br J Anaesth 105(3):318–325
Silvestre J, Coelho L, Povoa P (2010) Should C-reactive protein concentration at ICU discharge be used as a prognostic marker? BMC Anesthesiol 10:17
Ranzani OT, Prada LF, Zampieri FG, et al (2012) Failure to reduce C-reactive protein levels more than 25% in the last 24 hours before intensive care unit discharge predicts higher in-hospital mortality: a cohort study. J Crit Care 27(5):525.e9–15
Ahmadi-Kashani M, Kessler DJ, Day J, Bunch TJ, Stolen KQ, Brown S, Sbaity S, Olshansky B, INTRINSIC RV Study Investigators (2009) Heart rate predicts outcomes in an implantable. Circulation. 120(21):2040–2045
Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K (2011) Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine: MODI (f)Y trial. Clin Res Cardiol 100(10):915–923
Diaz A, Bourassa MG, Guertin MC et al (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26(10):967–974
Fagundes JE, Castro I (2010) Predictive value of resting heart rate for cardiovascular and all-cause mortality. Arq Bras Cardiol 95(6):713–719
Povoa P (2002) C-reactive protein: a valuable marker of sepsis. Intensive Care Med 28(3):235–243
Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454
Acknowledgments
Raffaella Gothe; Dip-Stat.: Center of Statistical Consulting. UMIT; Austria.
Conflict of interest
No author has a conflict of interest in regards of drugs or techniques discussed in this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grander, W., Müllauer, K., Koller, B. et al. Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness. Clin Res Cardiol 102, 599–606 (2013). https://doi.org/10.1007/s00392-013-0571-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-013-0571-4